Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 219

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure

Wever, Robert, Boer, Peter, Hijmering, Michel, Stroes, Erik, Verhaar, Marianne, Kastelein, John, Versluis, Kees, Lagerwerf, Fija, van Rijn, Herman, Koomans, Hein, Rabelink, Ton · 1999 · Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Abstract —In patients with chronic renal failure (CRF), atherosclerosis is a major cause of cardiovascular morbidity and mortality. Generally, atherosclerosis has been associated with a reduced bioavailability of nitric oxide (NO). Experimental studies have indicated the presence of enhanced NO degradation by reactive oxygen species as well as decreased NO production as possible causes for this reduced NO bioavailability. So far, the question whether or not NO production is impaired in patients with CRF has never been investigated. Therefore, we measured whole body NO production in 7 patients with CRF, and in 7 matched healthy subjects. To assess the relative importance of a dysfunction of NO synthase (NOS), we compared the NO production of these patients to that of 2 other groups known to have endothelial dysfunction, ie, 7 patients with familial hypercholesterolemia (FH) who did not yet have signs of clinical cardiovascular disease (all nonsmokers), and 5 cigarette smokers. These groups were also compared with 7 nonsmoking, age-matched healthy subjects. Whole body NO production, determined as in vivo arginine-to-citrulline conversion, was assessed by giving an intravenous infusion of [ 15 N 2 ]-arginine as a substrate for NOS and measuring isotopic plasma enrichment of [ 15 N]-citrulline by LC-MS. NO production in the CRF patients (0.13±0.02 μmol · kg –1 · h –1 ) was significantly lower ( P <0.05) than in the corresponding control group (0.23±0.09 μmol · kg –1 · h –1 ). NO production also tended to be lower in the FH patients (0.16±0.04 μmol · kg –1 · h –1 ), but the difference with the corresponding control group did not reach significance (0.22±0.06 μmol · kg –1 · h –1 ). In the group of smokers, NO production was similar to that in nonsmokers (0.22±0.09 μmol · kg –1 · h –1 ). In conclusion, it is demonstrated for the first time that basal whole body NO production is reduced in patients with CRF. This finding implies that therapeutic interventions to endothelial dysfunction in these patients should be primarily directed toward improvement of NO production. The finding of only a tendency toward reduction of NO production in patients with FH and the absence of a reduction in cigarette smokers suggests that other mechanisms such as enhanced NO degradation may be involved in the decrease of NO bioavailability in these groups.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.19.5.1168

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 219

Metadata

Authors
Wever, R., Boer, P., Hijmering, M., Stroes, E., Verhaar, M., Kastelein, J., Versluis, K., Lagerwerf, F., van Rijn, H., Koomans, H., & Rabelink, T.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
1999-05
Volume
19
Issue
5
Pages
1168-1172
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2035655266
Cited by
219
References
2
FWCI
5.02
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure. https://app.cochat.ai/papers/10.1161/01.atv.19.5.1168
The paper
Wever, R., Boer, P., Hijmering, M., Stroes, E., Verhaar, M., Kastelein, J., Versluis, K., Lagerwerf, F., van Rijn, H., Koomans, H., & Rabelink, T. (1999). Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.19.5.1168

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.